Last10K.com

Sinovac Biotech Ltd (SVA) SEC Filing 20-F Annual report for the fiscal year ending Wednesday, December 31, 2014

Sinovac Biotech Ltd

HISTORY TOOLS
CIK: 1084201 Ticker: SVA

View differences made from one year to another to evaluate Sinovac Biotech Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sinovac Biotech Ltd.

Continue

Assess how Sinovac Biotech Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sinovac Biotech Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income (loss)
Consolidated Statements Of Comprehensive Income (loss) (parenthetical)
Consolidated Statements Of Shareholders' Equity
Accounts Payable And Accrued Liabilities
Accounts Payable And Accrued Liabilities (details)
Accounts Payable And Accrued Liabilities (tables)
Accounts Receivable - Net
Accounts Receivable - Net (details)
Accounts Receivable - Net (tables)
Bank Loans And Other Debt
Bank Loans And Other Debt (details)
Bank Loans And Other Debt (tables)
Basis Of Presentation
Basis Of Presentation (details)
Basis Of Presentation (tables)
Collaboration Agreements
Collaboration Agreements (details)
Commitments And Contingencies
Commitments And Contingencies (details)
Commitments And Contingencies (tables)
Common Stock
Common Stock (details)
Condensed Financial Information Of The Parent Company
Condensed Financial Information Of The Parent Company (details 2)
Condensed Financial Information Of The Parent Company (details 3)
Condensed Financial Information Of The Parent Company (details)
Condensed Financial Information Of The Parent Company (tables)
Deferred Government Grants
Deferred Government Grants (details)
Deferred Revenue
Deferred Revenue (details)
Earnings (loss) Per Share
Earnings (loss) Per Share (details)
Earnings (loss) Per Share (tables)
Income Taxes
Income Taxes (details)
Income Taxes (tables)
Inventories
Inventories (details)
Inventories (tables)
Licenses
Licenses (details)
Licenses (tables)
Long-term Inventories
Long-term Inventories (details)
Long-term Inventories (tables)
Non-controlling Interests
Non-controlling Interests (details)
Prepaid Land Lease Payments
Prepaid Land Lease Payments (details)
Prepaid Land Lease Payments (tables)
Property, Plant And Equipment
Property, Plant And Equipment (details)
Property, Plant And Equipment (tables)
Related Party Transactions And Balances
Related Party Transactions And Balances (details)
Related Party Transactions And Balances (tables)
Segmented Information
Segmented Information (details)
Segmented Information (tables)
Significant Accounting Policies
Significant Accounting Policies (details 2)
Significant Accounting Policies (details 3)
Significant Accounting Policies (details 4)
Significant Accounting Policies (details 5)
Significant Accounting Policies (details 6)
Significant Accounting Policies (details)
Significant Accounting Policies (policies)
Significant Accounting Policies (tables)
Statutory Surplus Reserves
Statutory Surplus Reserves (details)
Stock Options
Stock Options (details 2)
Stock Options (details 3)
Stock Options (details)
Stock Options (tables)
Subsequent Events
Subsequent Events (details)
Ticker: SVA
CIK: 1084201
Form Type: 20-F Annual Report
Accession Number: 0001104659-15-031226
Submitted to the SEC: Wed Apr 29 2015 6:23:32 AM EST
Accepted by the SEC: Wed Apr 29 2015
Period: Wednesday, December 31, 2014
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/sva/0001104659-15-031226.htm